NCT02461121 HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk Status COMPLETED Phase PHASE3
NCT02446145 A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients Status TERMINATED Phase PHASE2
NCT02440568 AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients Status TERMINATED Phase PHASE1/PHASE2
NCT02432911 Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old Status UNKNOWN Phase NA
NCT02432872 Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years Status UNKNOWN Phase NA
NCT02424968 CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma Status COMPLETED Phase PHASE2
NCT02419755 Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT02416908 Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT02413021 The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens Status UNKNOWN Phase PHASE1
NCT02410252 Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies Status COMPLETED Phase NA
NCT02403310 A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML Status COMPLETED Phase PHASE1
NCT02400281 Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients Status COMPLETED Phase PHASE1/PHASE2
NCT02400255 Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients Status COMPLETED Phase PHASE2
NCT02392429 FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02390635 PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia Status RECRUITING Phase PHASE1
NCT02381548 Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT02367456 A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients Status COMPLETED Phase PHASE1